RNA-seq results between the recurrent implantation failure (RIF) and control groups

From July 2017 to December 2018, 54 women (aged between 23 and 39 years) who were treated at the Reproductive Medicine Center of Affiliated Drum Tower Hospital were enrolled in this study. All women exhibited a regular menstrual cycle ranging from 28-33 days, and none of them received hormonal therapy in the last three months. The exclusion criteria included polycystic ovarian syndrome (PCOS), hydrosalpinx, endometriosis, adenomyosis, endometrial hyperplasia or endometrial polyps.

本研究纳入了2017年7月至2018年12月期间，于附属鼓楼医院生殖医学中心就诊的54名女性受试者，其年龄介于23至39岁之间。所有受试者的月经周期均规律，为28至33天，且近3个月内未接受过激素治疗。本研究的排除标准包括：多囊卵巢综合征（polycystic ovarian syndrome, PCOS）、输卵管积水、子宫内膜异位症、子宫腺肌病、子宫内膜增生或子宫内膜息肉。